Summary: At the European Respiratory Society Congress, BMC Medical Co highlighted its PAP Link telemedicine solution and new advancements in sleep and respiratory healthcare, focusing on how AI and digital health can enhance patient outcomes and improve the efficiency of positive airway pressure (PAP) therapies. Experts discussed the evolving role of telemonitoring in respiratory care and the impact of AI on doctor-patient relationships.
Key Takeaways:
- PAP Link Solution: BMC’s PAP Link integrates data from CPAP/BPAP devices, allowing for real-time monitoring of sleep and respiratory events, aimed at improving therapy compliance and reducing treatment termination rates.
- Telemedicine’s Benefits: Industry research has shown that telemedicine monitoring devices can reduce the rate of PAP termination, increase CPAP compliance, and lower patient costs.
- AI in Respiratory Care: Discussions at the congress centered on balancing AI’s role in respiratory medicine with human input, ensuring new technologies enhance, rather than replace, the doctor-patient relationship.
BMC Medical Co, a provider of sleep and respiratory care solutions, was present as one of the exhibitors at the European Respiratory Society (ERS) Congress in Vienna, Austria, facilitating courses on data in telemedicine and introducing the newest technology and products in sleep and respiratory healthcare.
Under the theme of “Humans and machines: getting the balance right,” scholars from Europe, North America, Asia, and Australia shared insights on the latest advancements in artificial intelligence (AI) in respiratory medicine, the future of digital healthcare, and the importance of maintaining the human role in AI-supported medical care.
Additionally, they explored how machines impact doctor-patient relationships and how new technologies will change healthcare systems and pathways.
Telemonitoring in PAP Device Therapy
In this context, BMC hosted experts who presented on the topic of “How can G3 CPAP/BPAP and PAP Link digital health solution enhance patient outcomes.”. BMC’s PAP Link digital health solution, with data integration technology, offers new directions for sleep and respiratory event analysis and patient management.
This marked the first time BMC invited speakers and doctors specializing in sleep and respiratory care to discuss the influences of telemonitoring in PAP device therapy for both patients and doctors.
Previously, industry research has shown that telemedicine monitoring devices can reduce the rate of PAP termination, increase CPAP compliance, and lower patient costs. Doctors and sleep therapists can act more quickly and efficiently.
The company also invited experts from Italy, Bulgaria, and Romania to discuss the different benefits of telemedicine monitoring for physicians and patients during PAP therapy for sleep and respiratory care.
Photo caption: BMC attends ERS Congress
Photo credit: BMC Medical Co
Leave a Reply